In 2023, AstraZeneca reported a total of 6,937,716 ton CO₂e, and a net revenue of 45,811 M USD, resulting in a emissions intensity of 151.44 t CO₂e / M USD.
Base year:
2015
Target year:
2026
Reduction:
0.98
Classification:
1.5°C
Global biopharmaceutical company AstraZeneca commits to reduce absolute scope 1 and 2 GHG emissions 98% by FY2026 from a FY2015 base year
Source: Science Based Target initative
Emissions, Revenue & Intensity
Emissions, Target & Trend
Emissions Overview | 2015 | 2019 | 2021 | 2022 | 2023 |
Total Emissions - Market Based (t CO₂e) | 620,817 | 6,186,453 | 6,423,609 | 6,937,716 | |
---|---|---|---|---|---|
Emissions Intensity (t CO₂e / M USD) | 25.13 | 232.99 | 165.34 | 144.84 | 151.44 |
Cradle-to-gate Intensity (t CO₂e / M USD) | 25.13 | 183.27 | 138.96 | 120.05 | 119.07 |